Tempest Therapeutics Inc (TPST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 26,575 | 42,026 | 29,157 | 34,640 | 26,986 |
| Operating Income | -26,575 | -42,026 | -29,157 | -34,640 | -26,986 |
| Interest Expense | 207 | 1,316 | 1,449 | 1,618 | 1,282 |
| Other Income | 520 | 1,499 | 1,115 | 549 | -34 |
| Pre-tax Income | -26,262 | -41,843 | -29,491 | -35,709 | -28,302 |
| Net Income Continuous | -26,262 | -41,843 | -29,491 | -35,709 | -28,302 |
| Net Income | $-26,262 | $-41,843 | $-29,491 | $-35,709 | $-28,302 |
| EPS Basic Total Ops | -6.33 | -19.50 | -24.84 | -40.18 | -97.14 |
| EPS Basic Continuous Ops | -6.33 | -19.50 | -24.88 | -40.21 | -97.11 |
| EPS Diluted Total Ops | -6.33 | -19.50 | -24.84 | -40.18 | -97.14 |
| EPS Diluted Continuous Ops | -6.33 | -19.50 | -24.88 | -40.21 | -97.11 |
| EPS Diluted Before Non-Recurring Items | -6.33 | -19.51 | -24.84 | -40.18 | -97.14 |
| EBITDA(a) | $-26,309 | $-41,637 | $-28,776 | $-34,002 | $-26,612 |